{"id":911796,"date":"2026-06-10T15:18:14","date_gmt":"2026-06-10T20:18:14","guid":{"rendered":"https:\/\/newsycanuse.com\/index.php\/2026\/06\/10\/just-in-drugmaker-asks-us-supreme-court-to-restore-mail-access-to-abortion-pill\/"},"modified":"2026-06-10T15:18:14","modified_gmt":"2026-06-10T20:18:14","slug":"just-in-drugmaker-asks-us-supreme-court-to-restore-mail-access-to-abortion-pill","status":"publish","type":"post","link":"https:\/\/newsycanuse.com\/index.php\/2026\/06\/10\/just-in-drugmaker-asks-us-supreme-court-to-restore-mail-access-to-abortion-pill\/","title":{"rendered":"JUST IN: Drugmaker Asks US Supreme Court to Restore Mail Access to Abortion Pill"},"content":{"rendered":"
\n

WASHINGTON, USA \u2014 Danco Laboratories, a maker of the abortion drug mifepristone, asked the Supreme Court on Saturday, May 2, 2026, to temporarily block a federal appeals court ruling<\/a> that cut off telehealth and mail access to the medication nationwide.<\/p>\n

The emergency application followed a unanimous ruling by the U.S. Court of Appeals for the Fifth Circuit, which reinstated an earlier requirement that patients obtain mifepristone in person from a medical provider.<\/p>\n

The order applies across the country, including in states where abortion remains legal.<\/p>\n

Danco asked the justices for an immediate administrative stay while the case continues, arguing that the lower court\u2019s order would create widespread uncertainty for patients, pharmacies and clinicians.<\/p>\n

The Supreme Court will now decide whether to overrule an appeals court that found in Louisiana’s favor. | AFP via Getty Images<\/p>\n

” data-large-file=”https:\/\/www.thetrentonline.com\/wp-content\/uploads\/2026\/05\/Supreme-Court-Activist-The-Trent-1024×683.jpg” src=”https:\/\/www.thetrentonline.com\/wp-content\/uploads\/2026\/05\/Supreme-Court-Activist-The-Trent.jpg” alt=”Abortion Pill” width=”1200″ height=”800″ >

The Supreme Court will now decide whether to overrule an appeals court that found in Louisiana\u2019s favor. | AFP via Getty Images<\/figcaption><\/figure>\n

Company Warns of \u201cImmediate Chaos\u201d<\/strong><\/h2>\n

In its emergency filing, Danco said the appeals court had disrupted a federal policy that had been in place for years, allowing mifepristone to be prescribed through telehealth and sent by mail.<\/p>\n

The company first asked the Fifth Circuit on Friday night to pause its own order for one week.<\/p>\n

After the court did not immediately act, Danco turned to the Supreme Court.<\/p>\n

The company argued that without intervention, \u201ctremendous uncertainty will surround the legal status of mifepristone throughout the country.\u201d<\/p>\n

GenBioPro, another manufacturer of mifepristone, is expected to file its own appeal.<\/p>\n

\"abortion<\/p>\n

Fifth Circuit Sides With Louisiana<\/strong><\/h2>\n

The case was brought by Louisiana, which challenged Food and Drug Administration rules that expanded access to mifepristone by allowing remote prescribing and mail delivery.<\/p>\n

Louisiana argued that the policy threatened women\u2019s safety and interfered with the state\u2019s abortion restrictions.<\/p>\n

The Fifth Circuit agreed to pause the FDA rule while the case proceeds.<\/p>\n

The decision reversed a lower court order that had allowed the policy to remain in place while the Trump administration conducted a safety review of mifepristone.<\/p>\n

The ruling requires mifepristone to be dispensed in person, limiting access by telehealth and mail.<\/p>\n

Supporters of Florida’s Amendment 4, which would have enshrined abortion rights in the state, react in St. Petersburg, Florida, after\u00a0the amendment’s defeat.\u00a0| Rebecca Blackwell\/AP<\/p>\n

” data-large-file=”https:\/\/www.thetrentonline.com\/wp-content\/uploads\/2025\/02\/c-ap24311117494394-1024×683.jpg” src=”https:\/\/www.thetrentonline.com\/wp-content\/uploads\/2025\/02\/c-ap24311117494394.jpg” alt=”Florida, 4th amendment, Abortion” width=”1110″ height=”740″ >

Supporters of Florida\u2019s Amendment 4, which would have enshrined abortion rights in the state, react in St. Petersburg, Florida, after\u00a0the amendment\u2019s defeat.\u00a0| Rebecca Blackwell\/AP<\/figcaption><\/figure>\n

Abortion Access and Miscarriage Care<\/strong><\/h2>\n

Mifepristone is commonly used with misoprostol in medication abortion and is also used in miscarriage management.<\/p>\n

Medication abortion accounts for more than 60 per cent of abortions in the United States, according to the Guttmacher Institute.<\/p>\n

Advocacy groups said the decision would affect patients who rely on telehealth services, including those living far from clinics.<\/p>\n

Some groups noted that misoprostol can still be prescribed through telehealth and used on its own in abortion care, though it is a different regimen.<\/p>\n

Elisa Wells, co-founder of Plan C, said the ruling would not end pills-by-mail abortion care.<\/p>\n

\u201cExtremist attempts to limit access to abortion have not been successful at stopping the pills-by-mail model of safe abortion care, and this court decision will also not stop access,\u201d she said.<\/p>\n

Father Fidelis Moscinski (lower left, standing behind the cross), a well-known pro-life activist and priest of the Franciscan Friars of the Renewal (CFR) is seen during a tense standoff between pro-life and pro-abortion demonstrators in Lower Manhattan on July 2, 2022. The pro-life marchers were trying to reach a Planned Parenthood abortion clinic where they planned to hold a prayer vigil, and the pro-abortion demonstrators were trying to block their path. | Jeffrey Bruno\/CNA<\/p>\n

” data-large-file=”https:\/\/www.thetrentonline.com\/wp-content\/uploads\/2023\/07\/Abortion-Clinic-Protest-The-Trent.jpg” src=”https:\/\/www.thetrentonline.com\/wp-content\/uploads\/2023\/07\/Abortion-Clinic-Protest-The-Trent.jpg” alt=”Father Fidelis Moscinski , Catholic Priest” width=”1000″ height=”670″ >

Father Fidelis Moscinski (lower left, standing behind the cross), a well-known pro-life activist and priest of the Franciscan Friars of the Renewal (CFR) is seen during a tense standoff between pro-life and pro-abortion demonstrators in Lower Manhattan on July 2, 2022. The pro-life marchers were trying to reach a Planned Parenthood abortion clinic where they planned to hold a prayer vigil, and the pro-abortion demonstrators were trying to block their path. | Jeffrey Bruno\/CNA<\/figcaption><\/figure>\n

Pharmaceutical Industry Raises Broader Concerns<\/strong><\/h2>\n

The ruling also drew concern from biotechnology executives, who warned that courts were intruding into the FDA\u2019s scientific and regulatory authority.<\/p>\n

\u201cBy circumventing the FDA\u2019s regulatory authority, this ruling threatens the evidence-based framework that has enabled generations of Americans to access safe, innovative medicines,\u201d said Shehnaaz Suliman, chief executive of ReCode Therapeutics.<\/p>\n

Julia Owens, chief executive of Basking Biosciences Inc., said such decisions risk undermining science-based health policy, innovation and patient access.<\/p>\n

Wider Legal Fight<\/strong><\/h2>\n

The Supreme Court previously rejected a separate challenge to mifepristone access in 2024, ruling that the plaintiffs in that case lacked standing.<\/p>\n

The current case, brought by Louisiana, presents a new path for opponents of abortion access because it is led by a state rather than private medical groups.<\/p>\n

The justices will now decide whether to pause the Fifth Circuit\u2019s order while the broader dispute continues in the lower courts.<\/p>\n<\/div>\n

Read More<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"

WASHINGTON, USA \u2014 Danco Laboratories, a maker of the abortion drug mifepristone, asked the Supreme Court on Saturday, May 2, 2026, to temporarily block a federal appeals court ruling that cut off telehealth and mail access to the medication nationwide. The emergency application followed a unanimous ruling by the U.S. Court of Appeals for the<\/p>\n","protected":false},"author":1,"featured_media":911797,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[35073,1829],"tags":[19548,7078],"class_list":["post-911796","post","type-post","status-publish","format-standard","has-post-thumbnail","category-drugmaker","category-supreme","tag-drugmaker","tag-supreme"],"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/newsycanuse.com\/index.php\/wp-json\/wp\/v2\/posts\/911796","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/newsycanuse.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/newsycanuse.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/newsycanuse.com\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/newsycanuse.com\/index.php\/wp-json\/wp\/v2\/comments?post=911796"}],"version-history":[{"count":0,"href":"https:\/\/newsycanuse.com\/index.php\/wp-json\/wp\/v2\/posts\/911796\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/newsycanuse.com\/index.php\/wp-json\/wp\/v2\/media\/911797"}],"wp:attachment":[{"href":"https:\/\/newsycanuse.com\/index.php\/wp-json\/wp\/v2\/media?parent=911796"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/newsycanuse.com\/index.php\/wp-json\/wp\/v2\/categories?post=911796"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/newsycanuse.com\/index.php\/wp-json\/wp\/v2\/tags?post=911796"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}